Evidence map›Paper›PMID 40975076›Full record

ArticleThe Lancet. Global health2025

Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health: a modelling study.

John Stover, Emily Sonneveldt, Yvonne Tam, Katherine C Horton, Andrew N Phillips, Jennifer Smith, Rowan Martin-Hughes, Debra Ten Brink, Daniel T Citron, Hae-Young Kim and 18 more

Abstract read
In one paragraph

Article in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. A model for the epidemiological impact of tuberculosis policy options.Bulletin of the World Health Organization · 2026
    Article
  15. Article
  16. Article
  17. Progress and Challenges in Elimination of Vertical HIV Transmission.Journal of the International AIDS Society · 2026
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

John StoverAvenir Health, Glastonbury, CT USA. Electronic address: JStover@AvenirHealth.org.
Emily SonneveldtAvenir Health, Glastonbury, CT USA.
Yvonne TamDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Katherine C HortonDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.
Andrew N PhillipsDepartment of Infection and Population Health, University College London, London, UK.
Jennifer SmithDepartment of Infection and Population Health, University College London, London, UK.
Rowan Martin-HughesBurnet Institute, Melbourne, VIC, Australia.
Debra Ten BrinkBurnet Institute, Melbourne, VIC, Australia.
Daniel T CitronDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Hae-Young KimDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Adam AkullianInstitute for Disease Modeling, Gates Foundation, Seattle, Washington, USA.
Edinah MudimuDepartment of Decision Sciences, University of South Africa, Pretoria, South Africa.
Michael PicklesSchool of Public Health, Imperial College London, London, UK.
Anna BershteynDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Jessica WilliamsonAvenir Health, Glastonbury, CT USA.
Gesine Meyer-RathHealth Economics and Epidemiology Office (HE2RO), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Lise JamiesonHealth Economics and Epidemiology Office (HE2RO), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; The South African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Elizabeth A SullyGuttmacher Institute, New York City, NY, USA.
Julia N WhiteReproductive Health Supplies Coalition, Washington, DC, USA.
Alexis HeatonReproductive Health Supplies Coalition, Washington, DC, USA.
Rebecca A ClarkDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.
Hannah TongDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Alexandra S RichardsDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.
C Finn McQuaidDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.
Rein M G J HoubenDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.
Richard G WhiteDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.
Dobromir DimitrovVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
David KaftanDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
Can mental health services break the cycle perpetuating HIV hotspots in sub-Saharan Africa?R01MH124478 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERSHTEYN, ANNA · 2021 to 2025
$3.2M
Leveraging HIV care systems to improve cardiovascular disease prevention in the Kingdom of eSwatiniR01HL169021 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Ronald Scott Braithwaite · 2023 to 2026
$3.1M
Rapid Tests for Recent Infection (RTRI) for Precision Public Health in Sub-Saharan Africa: Next-Generation Strategies Amid Changing HIV EpidemiologyR01AI174932 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Ronald Scott Braithwaite · 2023 to 2026
$3.0M
Drug concentration measurement for HIV prevention targets: toward a population-based HIV impact assessment (PHIA) for PrEPR01AI179417 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Anna Bershteyn, Dobromir Dimitrov · 2024 to 2026
$2.5M
Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking wellR01AI147321 · NIAID · LONDON SCH/HYGIENE & TROPICAL MEDICINE · PI GRANT, ALISON · 2019 to 2024
$2.3M
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effectiveR01MH130238 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERSHTEYN, ANNA · 2022 to 2024
$2.2M
Bill & Melinda Gates Foundation INV-001754Bill & Melinda Gates Foundation INV-019496Bill & Melinda Gates Foundation INV-035506Bill & Melinda Gates Foundation INV-040455NHLBI NIH HHS R01 HL169021NIAID NIH HHS R01 AI147321NIAID NIH HHS R01 AI174932NIAID NIH HHS R01 AI179417NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIMH NIH HHS R01 MH124478NIMH NIH HHS R01 MH130238Wellcome Trust
6 · The paper itself

Abstract

backgroundThe USA has traditionally been the largest donor to health programmes in low-income and middle-income countries (LMICs). In January 2025, almost all such funding was stopped and prospects for its resumption are uncertain. The suddenness of the funding cuts makes it difficult for national health programmes in LMICs to adapt. We aimed to estimate the impact of these cuts on deaths and other outcomes (new infections, number of family planning users, and unplanned pregnancies) for four health areas that have been a focus of a substantial amount of US foreign assistance: HIV, tuberculosis, family planning, and maternal and child health.

methodsWe applied established mathematical models to the countries receiving US foreign assistance in each domain to estimate health impacts over the period 2025 to 2030. We used six models of HIV, three different approaches to estimate family planning impact, and one model each for tuberculosis and maternal and child health, applying these models to as many as 80 countries. We compared model projections assuming constant funding (status quo) with projections assuming complete elimination of US funding in each country. Some models also considered partial cuts or restoration of funding over time.

findingsA complete cessation of US funding without replacement by other sources would lead to drastic increases in deaths from 2025 to 2030: 4·1 million (range 1·6-6·6) additional AIDS-related deaths across 55 countries, 606 900 (95% uncertainty interval [UI] 466 000-768 800) additional tuberculosis deaths across 79 countries, 40-55 million additional unplanned pregnancies and 12-16 million unsafe abortions across 51 countries, and 2·5 million (1·3-4·5) additional child deaths from causes other than HIV and tuberculosis across 24 countries. Restoration of funding for HIV treatment but not prevention would avoid most of the increase in deaths but still result in nearly 1 million more new HIV infections from 2025 to 2030.

interpretationSubstantial progress has been made in improving global health in the past few decades. This progress has strengthened hope in reaching global development goals. However, the recent funding cuts threaten to change these trajectories and could lead to sharp increases in avoidable mortality for the poorest countries. Even a partial restoration of US funding would combat the most severe effects and provide time for countries that have received substantial US foreign assistance to adjust to the new funding landscape.

fundingEconomic and Social Research Council; Engineering and Physical Sciences Research Council; European and Developing Countries Clinical Trials Partnership; Gates Foundation; Global Fund to Fight AIDS, Tuberculosis, and Malaria; Open Philanthropy; UK Foreign, Commonwealth & Development Office; UK Medical Research Council; UN Population Fund; UNAIDS; US National Institute of Allergy and Infectious Diseases; University of Edinburgh; US National Institutes of Health; US President's Emergency Plan for AIDS Relief; Wellcome Trust; World Bank; WHO.

Indexed as

Child HealthFamily Planning ServicesHIV InfectionsInternational CooperationMaternal HealthTuberculosisChildDeveloping CountriesFemaleGlobal HealthHumansModels, TheoreticalPregnancyUnited States

Identifiers

PMID40975076
PMCPMC12447089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.